Skip to main content
Log in

The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Purpose

Basaloid squamous cell carcinoma (BSCC) of the head and neck is an aggressive and highly malignant variant of squamous cell carcinoma that accounts for 2% of head and neck cancers. Previous studies have not analyzed the significance of adjuvant chemoradiation and anatomical site within BSCC subtype and its impact on survival.

Methods

A cohort of 1999 patients with BSCC of the head and neck was formed from the National Cancer Database and analyzed with descriptive studies, median survival and 5- and 10-year survival. A multivariable Cox hazard regression was performed to determine the prognostic significance of anatomical site and adjuvant therapy.

Results

The most common primary anatomical site was the oropharynx (71.9%) followed by oral cavity (11.5%), larynx (10.1%), hypopharynx (3.5%), esophagus (1.9%), and nasopharynx (1.1%). The presence of metastasis increased the risk of mortality (HR = 2.14; 95% CI 1.40–3.26). Tumors localized to the oropharynx demonstrated better survival compared to all sites except nasopharynx, including the oral cavity (HR = 2.45; 95% CI 1.83–3.29), hypopharynx (HR = 2.58; 95% CI:1.64–4.05), and larynx (HR = 2.89; 95% CI:2.25–3.73). Adjuvant chemoradiation (HR = 0.36; 95% CI 0.23–0.58) and adjuvant radiation (HR = 0.38; 95% CI 0.23–0.64) had better survival outcomes compared to adjuvant chemotherapy. Patients with microscopic margins had better survival outcomes when compared to no surgery (HR = 0.38, 98% Cl 0.23–0.64) while there were no better survival outcomes of patients with macroscopic margins compared to no surgery.

Conclusion

This study illustrated that tumors in the oropharynx, lower age, adjuvant chemoradiation and radiation, and microscopic margins were associated with greater survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17:1158–66.

    CAS  PubMed  Google Scholar 

  2. Soriano E, Faure C, Lantuejoul S, et al. Course and prognosis of basaloid squamous cell carcinoma of the head and neck: a case–control study of 62 patients. Eur J Cancer. 2008;44(2):244–50.

    PubMed  Google Scholar 

  3. Wang LC, Wang L, Kwauk S, et al. Analysis on the clinical features of 22 basaloid squamous cell carcinoma of the lung. J Thorac Cardiovasc Surg. 2011;6(1):10.

    Google Scholar 

  4. Vargas Y, Do Carmo A, Neto H, et al. Basaloid squamous cell carcinoma: a case report of an unusual location. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2017;124(2):E95.

    Google Scholar 

  5. Kwon YS, Kim YM, Choi GW, et al. Pure basaloid squamous cell carcinoma of the uterine cervix: a case report. J Korean Med Sci. 2009;24(3):542–5.

    PubMed  PubMed Central  Google Scholar 

  6. Jain A, Katarkar A, Shah P, et al. Basaloid squamous cell carcinoma of the pinna: report of a rare case. Ear Nose Throat J. 2014;93(1):E19–21.

    PubMed  Google Scholar 

  7. Kuan E, Peng K, Bhuta S, et al. Basaloid squamous cell carcinoma of the maxilla: report of a case and literature review. Am J Otolaryngol. 2015;36(3):402–7.

    PubMed  Google Scholar 

  8. Patel PN, Mutalik VS, Rehani S, Radhakrishnan R. Basaloid squamous cell carcinoma of oral cavity with incongruent clinical course. BMJ Case Rep. 2013;Bcr2013200441-bcr2013200441

  9. Paulino AG, Singh B, Shah JP, Huvos AG. Basaloid squamous cell carcinoma of the head and neck. Laryngoscope. 2000;110:1479–82.

    CAS  PubMed  Google Scholar 

  10. Cardesa A, Slootweg P, Gale N, Franchi A. Pathology of the head and neck. Berlin: Springer; 2016.

    Google Scholar 

  11. Ereno C, Gaafar A, Garmendia M, Etxezarraga C, Bilbao FJ, Lopez JI. Basaloid squamous cell carcinoma of the head and neck: a clinicopathological and follow-up study of 40 cases and review of the literature. Head Neck Pathol. 2008;2:83–91.

    PubMed  PubMed Central  Google Scholar 

  12. Jumaily M, Faraj F, Zhang D, Walker RJ, Ward GM. Basaloid squamous cell carcinoma of the larynx: a national cancer database analysis. Otolaryngol Head Neck Surg. 2019;160(5):847–54.

    PubMed  Google Scholar 

  13. Fritsch VA, Lentsch EJ. Basaloid squamous cell carcinoma of the head and neck: location means everything. J Surg Oncol. 2014;109(6):616–22.

    PubMed  Google Scholar 

  14. Linton OR, Moore MG, Brigance JS, et al. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2013;139(12):1306–11.

    PubMed  Google Scholar 

  15. Shen W, Sakamoto N, Yang L. Cause-specific mortality prediction model for patients with basaloid squamous cell carcinomas of the head and neck: a competing risk analysis. J Cancer. 2018;9(21):4009–177.

    PubMed  PubMed Central  Google Scholar 

  16. Barnes L, Eveson JW, Reichart P, Sidransky D. World health organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005.

    Google Scholar 

  17. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805–13.

    CAS  PubMed  Google Scholar 

  18. Westra WH. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol. 2009;3:78–81.

    PubMed  PubMed Central  Google Scholar 

  19. Jacobi C, Ayx I, Fritsche K, et al. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck. Oncotarget. 2015;6(5):3462–70.

    PubMed  Google Scholar 

  20. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32:1044–50.

    PubMed  Google Scholar 

Download references

Funding

This manuscript had no funding sources.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Gootee.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Need for ethical approval was waived by the Creighton University Biomedical IRB (project number: 2000552) and formal consent was not required.

Informed consent

Informed consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gootee, J., Patel, M., Aurit, S. et al. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database. Clin Transl Oncol 22, 2264–2274 (2020). https://doi.org/10.1007/s12094-020-02370-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-020-02370-2

Keywords

Navigation